HUP0301197A2 - Diagnosztikumok és terápiás hatóanyagok idült obstruktív légúti megbetegedés kezelésére - Google Patents

Diagnosztikumok és terápiás hatóanyagok idült obstruktív légúti megbetegedés kezelésére

Info

Publication number
HUP0301197A2
HUP0301197A2 HU0301197A HUP0301197A HUP0301197A2 HU P0301197 A2 HUP0301197 A2 HU P0301197A2 HU 0301197 A HU0301197 A HU 0301197A HU P0301197 A HUP0301197 A HU P0301197A HU P0301197 A2 HUP0301197 A2 HU P0301197A2
Authority
HU
Hungary
Prior art keywords
chronic obstructive
therapeutics
diagnostics
airway disease
obstructive airway
Prior art date
Application number
HU0301197A
Other languages
English (en)
Inventor
Peter J. Barnes
Gordon W. Duff
Marco Giovine
Simon Lim
Original Assignee
Interleukin Genetics, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9723553.5A external-priority patent/GB9723553D0/en
Application filed by Interleukin Genetics, Inc. filed Critical Interleukin Genetics, Inc.
Publication of HUP0301197A2 publication Critical patent/HUP0301197A2/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A találmány tárgya eljárás idült obstruktív légúti megbetegedésre valóhajlam vagy idült obstruktív légúti megbetegedés kialakulásagyorsaságának vagy végkifejletének meghatározására. A találmánytárgyát képezik a találmány szerinti eljárás végrehajására alkalmásreagenskészletek is. A találmány szerinti reagenskészletek ésvizsgálati eljárások segítségével nyert információ elősegíti avizsgált személy megbetegedési esélyének előrejelzését. Ó
HU0301197A 1997-11-07 1998-11-09 Diagnosztikumok és terápiás hatóanyagok idült obstruktív légúti megbetegedés kezelésére HUP0301197A2 (hu)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9723553.5A GB9723553D0 (en) 1997-11-07 1997-11-07 Prediction of the risk of chronic obstructive airway disease
US09/005,923 US6140047A (en) 1997-11-07 1998-01-12 Method and kit for predicting susceptibility to asthma
PCT/US1998/023721 WO1999024615A2 (en) 1997-11-07 1998-11-09 Diagnostics and therapeutics for chronic obstructive airway disease

Publications (1)

Publication Number Publication Date
HUP0301197A2 true HUP0301197A2 (hu) 2003-07-28

Family

ID=26312564

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0301197A HUP0301197A2 (hu) 1997-11-07 1998-11-09 Diagnosztikumok és terápiás hatóanyagok idült obstruktív légúti megbetegedés kezelésére

Country Status (13)

Country Link
EP (1) EP1029079B1 (hu)
JP (1) JP2001522586A (hu)
AT (1) ATE383438T1 (hu)
AU (1) AU760856B2 (hu)
BR (1) BR9813950A (hu)
CA (1) CA2308570A1 (hu)
ES (1) ES2297900T3 (hu)
HU (1) HUP0301197A2 (hu)
IL (1) IL135957A0 (hu)
NO (1) NO20002176L (hu)
PL (1) PL340624A1 (hu)
TR (1) TR200001263T2 (hu)
WO (1) WO1999024615A2 (hu)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6251598B1 (en) * 1998-10-30 2001-06-26 Interleukin Genetics, Inc. Methods for diagnosing sepsis
CA2367294A1 (en) * 1999-04-02 2000-10-12 Interleukin Genetics, Inc. Prediction of risk of interstitial lung disease
AU7706000A (en) * 1999-09-22 2001-04-24 Genaissance Pharmaceuticals, Inc. Drug target isogenes: polymorphisms in the interleukin-1 beta gene
WO2002000933A2 (en) * 2000-06-23 2002-01-03 Interleukin Genetics, Inc. Screening assays for identifying modulators of the inflammatory or immune responses
WO2005019259A2 (en) * 2003-08-25 2005-03-03 Compugen Ltd. Variants of interleukin-1 receptor antagonist: compositions and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995001997A1 (en) * 1993-07-09 1995-01-19 Smithkline Beecham Corporation RECOMBINANT AND HUMANIZED IL-1β ANTIBODIES FOR TREATMENT OF IL-1 MEDIATED INFLAMMATORY DISORDERS IN MAN
US5674483A (en) * 1995-01-31 1997-10-07 National Jewish Medical And Research Center Treatment for diseases involving inflammation
US5686246A (en) * 1995-08-03 1997-11-11 Kornman; Kenneth S. Detecting genetic predisposition to periodontal disease
GB9711040D0 (en) * 1997-05-29 1997-07-23 Duff Gordon W Prediction of inflammatory disease

Also Published As

Publication number Publication date
JP2001522586A (ja) 2001-11-20
IL135957A0 (en) 2001-05-20
TR200001263T2 (tr) 2000-12-21
WO1999024615A3 (en) 1999-09-16
CA2308570A1 (en) 1999-05-20
PL340624A1 (en) 2001-02-12
ES2297900T3 (es) 2008-05-01
AU1386399A (en) 1999-05-31
NO20002176L (no) 2000-07-05
BR9813950A (pt) 2000-09-26
EP1029079A2 (en) 2000-08-23
ATE383438T1 (de) 2008-01-15
AU760856B2 (en) 2003-05-22
WO1999024615A2 (en) 1999-05-20
NO20002176D0 (no) 2000-04-27
EP1029079B1 (en) 2008-01-09

Similar Documents

Publication Publication Date Title
NO20074034L (no) Anvendelse av en probe, fremgangsmate og kit for in vitro diagnose samt anvendelse av et monoklonalt eller polyklonalt antistoff
Blomgren et al. A note on vowel centralization in stuttering and nonstuttering individuals
ATE462710T1 (de) Mutationen in nod2 sind bei patienten mit morbus crohn mit fibrostenosebildung assoziiert
DE69626683D1 (de) Verfahren zur feststellung von antipolymerantikörper und diagnosetestsatz zur feststellung von siliconabhängigen krankheiten
ATE131620T1 (de) Verfahren zum frühzeitigen nachweis von lungenkrebs
IL142971A0 (en) S100 proteins and autoantibodies as serum markers for cancer
HUP0301197A2 (hu) Diagnosztikumok és terápiás hatóanyagok idült obstruktív légúti megbetegedés kezelésére
Diehl et al. Vowels as islands of reliability
DE69839876D1 (de) Prostat-spezifisches-antigenformen und verfahren zu ihrer bestimmung
DE69628847D1 (de) Testverfahren und testsatz zur diagnose von autoimmunerkrankungen
ATE173830T1 (de) Verfahren zur bestimmung der quantität extrazellulärer bpi in körperflüssigkeiten
EP0563244A4 (en) Human phospholipase activating protein and methods for diagnosis of rheumatoid arthritis
DE69629381D1 (de) Verfahren zur bestimmung der alkoholkonsumrate
ATE359519T1 (de) Diagnostisches verfahren für chronische obstruktive lungen krankheit
DE69912453D1 (de) Verfahren und materialien zur diagnose instabiler angina
DK0777860T3 (da) Analyse af frit og kompleksbundet trypsinogen-2
BRPI0415562A (pt) reagente para avaliação diagnóstica e/ou prognóstica de carcinoma, métodos para determinação de p-lap que é um fator prognóstico em carcinoma, e para avaliação prognóstica de carcinoma, e, kit de imunoensaio para determinação da quantidade de p-lap presente em tecidos de carcinoma
DE69618451T2 (de) Verfahren zur feststellung einer allergie
ATE242487T1 (de) Verfahren zur bestimmung von schilddrüsen- autoantikörpern
DE69627352D1 (de) Verfahren zur identifizierung personen empfindlich für betahemolytischer streptococci-vermittelter neuropsychiatrischer krankheiten
WO2003091410A3 (en) Method of fingerprinting tissue samples
KR970702928A (ko) 크립토콕쿠스증에 대해 위험이 큰 면역약화된 환자의 동정 방법(Method to identify immunocompromised patients at high risk for cryptococcosis)
PT1297342E (pt) Metodo de diagnostico para a doenca de alzheimer com base em holo-transcobalamina ii
Vohradnik et al. Finite element model of supraglottal space in cleft palate
Nittrouer et al. Noise measurements of adult men's and women's voices